If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £65.92m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Statement re Offers for Subscription

5 Feb 2015 17:00

RNS Number : 2074E
Maven Income and Growth VCT 5 PLC
05 February 2015
 

Joint Announcement

 

Offers for Subscription - Maven VCT 5 Offer Fully Subscribed

 

Maven Income and Growth VCT plc ("Maven VCT 1"), Maven Income and Growth VCT 2 plc ("Maven VCT 2"), Maven Income and Growth VCT 3 plc ("Maven VCT 3"), Maven Income and Growth VCT 4 plc ("Maven VCT 4") and Maven Income and Growth VCT 5 plc ("Maven VCT 5") (together "the Companies" and each a "Company") are managed by Maven Capital Partners UK LLP ("Maven").

 

The Boards of the Companies launched offers for subscription to raise, in aggregate, up to £18 million ("the Offers" and each an "Offer"). Full details of the Offers are contained in a prospectus ("the Prospectus"), which was published by the Companies on 20 October 2014.

 

Further to the announcements of 7, 20 and 30 January and 3 February 2015 that the respective Offers by Maven VCT 4, Maven VCT 1, Maven VCT 3 and Maven VCT 2 were closed for further applications, the Companies are pleased to announce that applications have now been received for the full amount available under the Maven VCT 5 Offer and, as such, the Maven VCT Offers are now all fully subscribed and closed for further applications.

 

It is anticipated that the allotment of new ordinary shares by the Companies pursuant to the Offers in relation to the 2014/15 tax year will take place on or around 23 February 2015, as indicated in the Prospectus, and that the allotment of new ordinary shares by the Companies in relation to the 2015/16 tax year will take place as soon as practicable after 6 April 2015.

 

The Prospectus was submitted to the Financial Conduct Authority and copies of the Prospectus are available for download from the Companies' websites:

 

· www.mavencp.com/migvct

· www.mavencp.com/migvct2

· www.mavencp.com/migvct3

· www.mavencp.com/migvct4

· www.mavencp.com/migvct5

 

and from the National Storage Mechanism (http://www.hemscott.com/nsm.do). For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

5 February 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSSWFMIFISEIE
Date   Source Headline
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding
27th Mar 20251:06 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:53 pmRNSUnaudited Net Asset Value
18th Mar 20253:37 pmRNSAnnual Financial Report
28th Feb 20254:32 pmRNSTransaction in Own Shares
27th Feb 20251:54 pmRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:17 amRNSDirector/PDMR Shareholding
19th Feb 202510:14 amRNSDirector/PDMR Shareholding
19th Feb 202510:06 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
18th Dec 20249:35 amRNSIssue of Equity
13th Dec 20242:42 pmRNSNet Asset Value(s)
14th Nov 20242:55 pmRNSResult of General Meeting
25th Oct 20243:49 pmRNSTransaction in Own Shares
27th Sep 20244:31 pmRNSPublication of a Prospectus
6th Sep 202410:25 amRNSDirector/PDMR Shareholding
6th Sep 202410:01 amRNSIssue of Equity
5th Sep 20242:26 pmRNSStatement re Dividend Investment Scheme
5th Sep 20241:40 pmRNSUnaudited Net Asset Value
18th Jul 20245:27 pmRNSHalf-year Report
10th Jul 20245:08 pmRNSTransaction in Own Shares
8th Jul 20244:07 pmRNSStatement re NAV and Interim Dividend
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
10th May 20244:11 pmRNSTransaction in Own Shares
3rd May 20249:35 amRNSDirector/PDMR Shareholding
3rd May 20249:33 amRNSIssue of Equity
2nd May 20241:31 pmRNSResult of AGM
1st May 202410:06 amRNSDirector/PDMR Shareholding
1st May 202410:03 amRNSIssue of Equity
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.